• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉减少症的早期诊断和管理障碍:当前观点。

Obstacles to the Early Diagnosis and Management of Sarcopenia: Current Perspectives.

机构信息

Department of Ageing and Health, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London, UK.

Department of Twin Research and Genetic Epidemiology, School of Life Course and Population Sciences, St Thomas' Campus, King's College London, London, UK.

出版信息

Clin Interv Aging. 2024 Feb 20;19:323-332. doi: 10.2147/CIA.S438144. eCollection 2024.

DOI:10.2147/CIA.S438144
PMID:38404480
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10893890/
Abstract

Research in sarcopenia has grown exponentially over the last 15 years in geriatrics and gerontology, as well as other specialties, including oncology and hepatology. There is now strong evidence for the role of resistance exercise to prevent declines in muscle strength and function, especially when combined with nutritional optimization with protein supplementation. However, there remains a disparity between research evidence and clinical practice. There are multiple factors for this, which relate to the current diagnostic criteria for sarcopenia, practical and logistical aspects of diagnosis of sarcopenia, clinician knowledge of both diagnosis and management, and the availability of pathways for interventions. Sarcopenia is currently defined based on the identification of muscle strength, in combination with muscle size or quality, below cut-off thresholds at a single timepoint. This defines sarcopenia as a binary process of either present or not present, thus early diagnosis can be challenging. In this article, we summarize current obstacles to early diagnosis and management of sarcopenia in clinical practice, and make recommendations to how these might be overcome. This includes our recommendation of incorporation of handgrip strength measurement into standard care, to enable dynamic assessment and identification of early declines in handgrip strength, so that interventions can be implemented to prevent disability.

摘要

在过去的 15 年里,老年医学和老年学以及其他专业领域(包括肿瘤学和肝脏病学)的肌肉减少症研究呈指数级增长。现在有强有力的证据表明,阻力运动可以预防肌肉力量和功能的下降,尤其是与蛋白质补充的营养优化相结合时。然而,研究证据与临床实践之间仍然存在差距。造成这种情况的原因有很多,这些原因与目前的肌肉减少症诊断标准、肌肉减少症诊断的实际和后勤方面、临床医生对诊断和管理的了解程度以及干预措施的途径可用性有关。目前,肌肉减少症是根据单一时间点的肌肉力量结合肌肉大小或质量低于截止阈值来定义的。这将肌肉减少症定义为存在或不存在的二元过程,因此早期诊断可能具有挑战性。在本文中,我们总结了目前在临床实践中早期诊断和管理肌肉减少症的障碍,并就如何克服这些障碍提出了建议。这包括我们建议将握力测量纳入标准护理中,以实现对手握力的动态评估和早期下降的识别,从而可以实施干预措施来预防残疾。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaa/10893890/f04514ffbc03/CIA-19-323-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaa/10893890/f04514ffbc03/CIA-19-323-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeaa/10893890/f04514ffbc03/CIA-19-323-g0001.jpg

相似文献

1
Obstacles to the Early Diagnosis and Management of Sarcopenia: Current Perspectives.肌肉减少症的早期诊断和管理障碍:当前观点。
Clin Interv Aging. 2024 Feb 20;19:323-332. doi: 10.2147/CIA.S438144. eCollection 2024.
2
Adherence to a standardized protocol for measuring grip strength and appropriate cut-off values in adults over 65 years with sarcopenia: a systematic review protocol.65岁以上患有肌肉减少症的成年人握力测量的标准化方案及适当临界值:一项系统评价方案
JBI Database System Rev Implement Rep. 2015 Oct;13(10):50-9. doi: 10.11124/jbisrir-2015-2256.
3
Singapore multidisciplinary consensus recommendations on muscle health in older adults: assessment and multimodal targeted intervention across the continuum of care.新加坡老年人肌肉健康多学科共识建议:贯穿整个护理连续体的评估和多模式靶向干预。
BMC Geriatr. 2021 May 17;21(1):314. doi: 10.1186/s12877-021-02240-8.
4
Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition.根据老年肌少症欧洲工作组(EWGSOP)定义确定肌少症的切点。
Clin Nutr. 2016 Dec;35(6):1557-1563. doi: 10.1016/j.clnu.2016.02.002. Epub 2016 Feb 11.
5
Are sit-to-stand and isometric handgrip tests comparable assessment tools to identify dynapenia in sarcopenic people?坐站测试和等长握力测试是识别肌少症人群中无力的可比评估工具吗?
Arch Gerontol Geriatr. 2023 Nov;114:105059. doi: 10.1016/j.archger.2023.105059. Epub 2023 May 8.
6
Cut-off values for severe low muscle strength and skeletal muscle mass in post-acute patients with sarcopenia.肌少症急性后患者严重低肌肉力量和骨骼肌质量的截断值。
Geriatr Gerontol Int. 2023 Jul;23(7):493-499. doi: 10.1111/ggi.14599. Epub 2023 May 29.
7
Associations of Sarcopenia and Sarcopenic Obesity With Metabolic Syndrome Considering Both Muscle Mass and Muscle Strength.考虑肌肉量和肌肉力量的肌肉减少症和肌肉减少性肥胖与代谢综合征的关联
J Prev Med Public Health. 2016 Jan;49(1):35-44. doi: 10.3961/jpmph.15.055.
8
Definition, diagnosis, and treatment of respiratory sarcopenia.呼吸肌少肌症的定义、诊断与治疗
Curr Opin Clin Nutr Metab Care. 2024 May 1;27(3):210-218. doi: 10.1097/MCO.0000000000001003. Epub 2023 Nov 29.
9
Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia.亚洲肌少症共识报告:亚洲肌少症工作组报告
J Am Med Dir Assoc. 2014 Feb;15(2):95-101. doi: 10.1016/j.jamda.2013.11.025.
10
Nutritional interventions to improve muscle mass, muscle strength, and physical performance in older people: an umbrella review of systematic reviews and meta-analyses.营养干预措施对改善老年人肌肉量、肌肉力量和身体机能的效果:系统评价和荟萃分析的伞状综述。
Nutr Rev. 2021 Jan 9;79(2):121-147. doi: 10.1093/nutrit/nuaa011.

引用本文的文献

1
A Liposomal Strategy for Dual-Action Therapy in Sarcopenia: Co-Delivery of Caffeine and HAMA.一种用于少肌症双效治疗的脂质体策略:咖啡因与透明质酸微球的共递送
Int J Mol Sci. 2025 Jun 24;26(13):6031. doi: 10.3390/ijms26136031.
2
Association of triglyceride-glucose index and its combinations with sarcopenia among community-dwelling older adults: based on the Chongqing Aging and Sarcopenia Evaluation (CHASE) cohort.社区居住的老年人中甘油三酯-葡萄糖指数及其组合与肌肉减少症的关联:基于重庆衰老与肌肉减少症评估(CHASE)队列研究
Front Physiol. 2025 May 15;16:1595517. doi: 10.3389/fphys.2025.1595517. eCollection 2025.
3
The Association Between Sarcopenia Index and Aortic Valve Sclerosis in Coronary Artery Disease Patients: Insights from a Retrospective Cross-Sectional Analysis and Animal Models.

本文引用的文献

1
Investigating the impact of fluid status on the ultrasound assessment of muscle quantity and quality in the diagnosis of sarcopenia - a multidimensional cross-sectional study.探讨液体状态对肌少症超声评估中肌肉量和质量的影响 - 一项多维横断面研究。
BMC Geriatr. 2023 Aug 15;23(1):493. doi: 10.1186/s12877-023-04177-6.
2
The combined intervention of neuromuscular electrical stimulation and nutrition therapy: A scoping review.神经肌肉电刺激与营养疗法的联合干预:一项范围综述。
Clin Nutr ESPEN. 2023 Apr;54:239-250. doi: 10.1016/j.clnesp.2023.01.027. Epub 2023 Feb 1.
3
Effects of Whey Protein, Leucine, and Vitamin D Supplementation in Patients with Sarcopenia: A Systematic Review and Meta-Analysis.
冠心病患者肌肉减少症指数与主动脉瓣硬化之间的关联:一项回顾性横断面分析及动物模型的见解
Vasc Health Risk Manag. 2025 May 16;21:391-401. doi: 10.2147/VHRM.S520000. eCollection 2025.
4
Prevalence and Associated Factors of Dynapenia, Pre-Sarcopenia, and Sarcopenia in Korean Adults: A Cross-Sectional Epidemiological Study.韩国成年人中肌肉减少症前期、肌肉减少症的患病率及相关因素:一项横断面流行病学研究。
Medicina (Kaunas). 2025 Mar 24;61(4):575. doi: 10.3390/medicina61040575.
5
An Indian Consensus on Sarcopenia: Epidemiology, Etiology, Clinical Impact, Screening, and Therapeutic Approaches.印度肌肉减少症共识:流行病学、病因学、临床影响、筛查及治疗方法
Int J Gen Med. 2025 Mar 26;18:1731-1745. doi: 10.2147/IJGM.S510412. eCollection 2025.
6
Effectiveness of Protein-enriched oral nutritional supplements on muscle function in middle-aged and elderly women: A randomized controlled trial.富含蛋白质的口服营养补充剂对中老年女性肌肉功能的有效性:一项随机对照试验。
J Nutr Health Aging. 2025 May;29(5):100508. doi: 10.1016/j.jnha.2025.100508. Epub 2025 Feb 13.
7
Gut dysbiosis in primary sarcopenia: potential mechanisms and implications for novel microbiome-based therapeutic strategies.原发性肌肉减少症中的肠道菌群失调:潜在机制及对基于微生物群的新型治疗策略的启示
Front Microbiol. 2025 Jan 28;16:1526764. doi: 10.3389/fmicb.2025.1526764. eCollection 2025.
8
New horizons in hospital-associated deconditioning: a global condition of body and mind.医院相关性失能的新视野:身心的全球性状况。
Age Ageing. 2024 Nov 1;53(11). doi: 10.1093/ageing/afae241.
9
Vascular Impairment, Muscle Atrophy, and Cognitive Decline: Critical Age-Related Conditions.血管损伤、肌肉萎缩与认知衰退:关键的年龄相关病症
Biomedicines. 2024 Sep 13;12(9):2096. doi: 10.3390/biomedicines12092096.
10
Effect of Bimagrumab on body composition: a systematic review and meta-analysis.比马鲁单抗对身体成分的影响:系统评价和荟萃分析。
Aging Clin Exp Res. 2024 Sep 9;36(1):185. doi: 10.1007/s40520-024-02825-4.
乳清蛋白、亮氨酸和维生素 D 补充剂对肌少症患者的影响:系统评价和荟萃分析。
Nutrients. 2023 Jan 19;15(3):521. doi: 10.3390/nu15030521.
4
Insights into Pathogenesis, Nutritional and Drug Approach in Sarcopenia: A Systematic Review.肌肉减少症的发病机制、营养及药物治疗方法的见解:一项系统综述
Biomedicines. 2023 Jan 5;11(1):136. doi: 10.3390/biomedicines11010136.
5
Defining terms commonly used in sarcopenia research: a glossary proposed by the Global Leadership in Sarcopenia (GLIS) Steering Committee.定义肌少症研究中常用术语:肌少症全球领导力倡议(GLIS)指导委员会提出的术语表。
Eur Geriatr Med. 2022 Dec;13(6):1239-1244. doi: 10.1007/s41999-022-00706-5. Epub 2022 Nov 29.
6
A pooled analysis of the association between sarcopenia and osteoporosis.肌肉减少症与骨质疏松症相关性的汇总分析。
Medicine (Baltimore). 2022 Nov 18;101(46):e31692. doi: 10.1097/MD.0000000000031692.
7
Sarcopenia definition, diagnosis and treatment: consensus is growing.肌少症的定义、诊断和治疗:共识正在形成。
Age Ageing. 2022 Oct 6;51(10). doi: 10.1093/ageing/afac220.
8
Induced frailty and acute sarcopenia are overlapping consequences of hospitalisation in older adults.诱导性衰弱和急性肌肉减少症是老年人住院治疗的重叠后果。
J Frailty Sarcopenia Falls. 2022 Sep 1;7(3):103-116. doi: 10.22540/JFSF-07-103. eCollection 2022 Sep.
9
Effect of vitamin D monotherapy on indices of sarcopenia in community-dwelling older adults: a systematic review and meta-analysis.维生素 D 单药治疗对社区居住老年人肌少症指标的影响:系统评价和荟萃分析。
J Cachexia Sarcopenia Muscle. 2022 Jun;13(3):1642-1652. doi: 10.1002/jcsm.12976. Epub 2022 Mar 8.
10
Trajectories of muscle quantity, quality and function measurements in hospitalized older adults.住院老年患者肌肉量、质量和功能测量的轨迹。
Geriatr Gerontol Int. 2022 Apr;22(4):311-318. doi: 10.1111/ggi.14366. Epub 2022 Mar 4.